Scientific publications

Safety and tolerability of gabapentin

Viteri C. [SP]
Unidad de Epilepsias. Departamento de Neurología y Neurocirugía; Clínica Universitaria de Navarra, Pamplona, 31008, España.

Magazine: Revista de Neurología

Date: Feb 1, 2002

Neurology [SP]

OBJECTIVE
To review the information available regarding the safety and tolerability of gabapentin (GBP) in the treatment of epilepsy.

PATIENTS AND METHODS
We reviewed the reports in the literature on the safety, adverse effects and tolerance of GBP as treatment, used as monotherapy or associated with other drugs, in epilepsies in patients of all age groups, including children, adults and the elderly.

RESULTS
All published studies confirm that GBP is a well tolerated drug when used for monotherapy or associated with other antiepileptic drugs. The commonest adverse effects seen were somnolence, fainting, ataxia, nystagmus, tremor and headache. However, their incidence was low and intensity mild. There was no clear relationship between the dose given and appearance of side effects, except for fainting and somnolence.

CONCLUSIONS
GBP is a drug which is free of unwanted side effects. Its safety and tolerability profile is excellent for treatment of simple and complex partial crises, with or without generalization in epileptic patients of all ages.

CITATION  Rev Neurol. 2002 Feb 1-15;34(3):292-5

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra